The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation. Our ambition is to deliver new products to patients in diseases with high unmet medical need.
Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. By sustainably investing in R&D above the industrial average, Grünenthal is strongly committed to innovation.
Grünenthal is an independent, family-owned company headquartered in Aachen, Germany. Grünenthal is present in approx. 30 countries with affiliates in Europe, Latin America and the US. Its products are sold in more than 100 countries and approx. 5,200 employees are working for the Grünenthal Group worldwide.